Primary Care Clinics in Brielle, NJ Accepting Medicare
2 Primary Care Clinics found. Showing 1 - 2
 Makowski Medical Associates Pa Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 608 Union Ave, Brielle, NJ 08730 Phone: 732-528-5626 |
David I Kleinfeld, Md, Pa Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 1200 Riverview Dr, Brielle, NJ 08730 Phone: 732-292-0355 Fax: 732-292-0357 |
News Archive
BioTools unveils revolutionary family of portable raman microscopes
BioTool's revolutionary new family of portable Raman microscopes bridges the gap between microscopy and spectroscopy, bringing microRaman out of the lab and into the world at large, opening new opportunities for doing the same analyses in different locations with the same instrumentation.
Two upcoming votes in House part of GOP continuing assault on health law
House Speaker John Boehner said the chamber will vote next week to delay the 2010 health-care law's requirement that most Americans carry health insurance. At his weekly news conference today, the speaker said it's not fair for President Barack Obama's administration to keep that provision in effect while postponing enforcement of the requirement that businesses provide their workers with insurance (Hunter, 7/11).
State officials, companies examine possible new regulations
"California's largest health insurer is teaming with hospitals and doctors throughout the state to better share ways to improve patient safety and cut costs, leaders of the initiative said Tuesday. ... Woodland Hills-based Anthem Blue Cross is contributing $6 million toward" a series of knowledge-sharing meetings over the next three years (Helfand, 1/20).
Microbiome of first stool may predict infant's likelihood of developing obesity
Meconium—the earliest stool of an infant—is composed of materials ingested during the time the infant spends in the uterus.
Genentech's Avastin combination Phase III study in advanced stomach cancer does not meet primary endpoint
Genentech, Inc., a wholly owned member of the Roche Group, today announced that a Phase III study (AVAGAST) did not meet its primary endpoint of showing Avastin® (bevacizumab) plus Xeloda® (capecitabine) or 5-FU and cisplatin chemotherapy extended the lives of people with inoperable or advanced stomach (gastric) cancer, compared to chemotherapy alone.
› Verified 6 days ago